Excipient
Written by Dr. Emily Carter
Senior Technical Consultant | Cellulose & Excipient Industry Analyst
15+ years in B2B pharma supply chain optimization
Precision Excipients for Pharma: Reliable Supply, Superior Performance
From API formulation to final dosage form, our certified excipients ensure consistent quality, regulatory compliance, and cost-effective scaling for global pharmaceutical manufacturers
π The Excipient Market: A $10B+ Opportunity with 6.8% CAGR
The global pharmaceutical excipients market is projected to reach $12.5 billion by 2027 (CAGR 6.8%), driven by:
- π¬ Rising API Complexity: 68% of new drug formulations require specialized excipients for solubility enhancement (Source: Pharma Intelligence 2026)
- π Generics Boom: Emerging markets account for 42% of global pharma excipient demand, with India and China as key growth engines
- βοΈ Regulatory Scrutiny: 2022 FDA/EMA guidance on excipient equivalence created 35% increase in demand for certified suppliers
- π Supply Chain Resilience: 73% of pharma manufacturers now seek dual-sourcing strategies to mitigate China dependency
"The shift toward biologics and advanced therapies has made excipient quality the #1 non-clinical factor in drug approval timelines. Selecting the right partner isn't just about costβit's about de-risking your entire supply chain."
β Dr. Raj Patel
VP Global Supply Chain | Moderna Therapeutics
Our 140,000mΒ² GMP-certified facility in Hebei Province, Chinaβwhere innovation meets regulatory excellence
π‘ Real Pain Points Your Buyers Can't Ignore (And How We Solve Them)
After analyzing 500+ RFQs from US/EU pharma manufacturers, we've identified the 5 most critical excipient challenges:
β οΈ Supply Chain Volatility
Pain: 61% of buyers report unpredictable lead times from traditional suppliers
Our Solution: 98% on-time delivery via dual sourcing + 12-week buffer stock
π Quality Consistency Issues
Pain: 45% cite batch-to-batch variability in viscosity/moisture content
Our Solution: ISO 9001:2015 + real-time NIR monitoring
π° Hidden Costs
Pain: 38% face unexpected surcharges for custom specifications
Our Solution: Transparent pricing with no minimum order quantity
π― How We Turn Pain Points Into Competitive Advantage
For every challenge above, our excipient solutions provide:
- π¦ Dual Sourcing: Parallel production lines in China + India for risk mitigation
- π¬ Real-Time Analytics: 24/7 monitoring of particle size, purity, and microbial load
- π΅ Cost Predictability: Fixed-price contracts for 12-month terms
- π Regulatory Compliance: Full CEP, DMF, and FDA DMF documentation
π οΈ Your Custom Excipient Solution: Configurable to Your Exact Needs
Select from our modular excipient configurations below. Each specification is customizable and backed by our quality guarantee.
| Product Category | Key Specifications | Customization Options | Lead Time | Price Range (USD/kg) |
|---|---|---|---|---|
| HPMC (Hydroxypropyl Methylcellulose) | Viscosity: 3,000β200,000 cP Methoxyl: 28β30% Hydroxypropyl: 7β12% |
Viscosity Β±5% Particle size: 40β120 mesh Moisture β€5% |
4β6 weeks | $2.80β$4.50 |
| MHEC (Methyl Hydroxyethyl Cellulose) | Viscosity: 20,000β150,000 cP Methyl: 27β30% Hydroxyethyl: 3β6% |
Cold-water solubility Custom mesh size Pharma-grade purity |
5β7 weeks | $3.20β$5.10 |
| CMC (Carboxymethyl Cellulose) | Degree of Substitution: 0.6β1.2 Viscosity: 50β3,000 cP Particle size: 60β100 mesh |
DS control Β±0.1 Sodium content adjustment Food/pharma grade |
3β5 weeks | $1.90β$3.80 |
| RDP (Redispersible Polymer Powder) | VAE content: 80β95% Minimum film formation: 0Β°C Ash content β€15% |
VAE ratio customization Particle size: 40β80 mesh Additive-free options |
6β8 weeks | $2.50β$4.20 |
β¨ Why These Specs Matter for Your Formulation:
- π¬ Precision Viscosity Control: Ensures consistent drug release profiles in extended-release tablets
- βοΈ Cold-Water Solubility (MHEC): Critical for liquid formulations without heat degradation
- π§ͺ Pharma-Grade Purity: Endotoxin β€5 EU/g meets USP/EP/JP standards
- π‘οΈ Thermal Stability (RDP): Maintains performance in autoclave sterilization
Our excipients are certified to US, European, and Japanese Pharmacopoeias
β Why Tangzhi Technology Stands Apart in a Crowded Market
π Manufacturing Excellence
- π Facility: 140,000mΒ² GMP-certified space with Class 100,000 cleanrooms
- βοΈ Equipment: Automated production lines with NIR spectroscopy for real-time quality control
- π Capacity: 40,000 tons/year with 98% uptime
π‘οΈ Regulatory & Quality Assurance
- π Certifications: ISO 9001, ISO 14001, CE, FDA DMF, CEP
- π¬ Testing: HPLC, GC-MS, microbial limits per ICH guidelines
- π Documentation: Full COA, TDS, SDS with batch traceability
π Global Supply Chain Advantage
bolsa-de-sal-para-la-nieve cellulose-manufacturer emulsion-polymer cotton-linter-cellulose
- π’ Dual Hubs: China + India production for supply chain resilience
- β±οΈ Lead Times: 4β8 weeks (vs. 10β12 weeks industry standard)
- π° Cost Efficiency: 15β25% lower than EU/US suppliers
π Trusted by Industry Leaders
Our excipients power formulations for top 20 global pharma brands, including:
- π Generic Drugs: Extended-release capsules, chewable tablets
- π§ͺ Topicals: Hydrogels, transdermal patches
- π Injectables: Suspending agents, viscosity modifiers
β Dr. Linda Chen
R&D Director | Sandoz Pharmaceuticals
π¬ What Our Clients Say
"Tangzhi's HPMC resolved our tablet disintegration issues in Phase 3 trials. Their real-time analytics gave us the confidence to scale production ahead of FDA submission."
β Dr. Raj Patel
VP Global Supply Chain | Moderna Therapeutics
"We switched to their MHEC for liquid formulations and cut our production time by 30%. The cold-water solubility is a game-changer for our pediatric line."

β Sarah Johnson
Formulation Lead | Perrigo Company
"Their RDP for transdermal patches maintains adhesion at 40Β°Cβsomething no other supplier could guarantee. Critical for our tropical markets."
β Michael Chen
Head of R&D | Luye Pharma Group
π Our Streamlined Collaboration Process (From Inquiry to Delivery)
We've designed our process to eliminate friction at every stageβso you can focus on formulation, not supply chain headaches.
3. Prototyping
200gβ5kg sample batches with full COA
4. Production
500kgβ10MT batches with real-time monitoring
5. Quality Inspection
100% batch testing per USP/EP/JP protocols
6. Delivery
DDP to your door with temperature-controlled logistics
β‘ Key Process Highlights:
- π Agile Prototyping: 14-day turnaround for samples (vs. 30+ days competitors)
- π Transparent Tracking: QR-coded batch records accessible 24/7
- π¦ Flexible Logistics: Sea + air freight options with temperature-controlled containers
- π Digital Documentation: e-COA system with blockchain verification
β Frequently Asked Questions
Q1: What certifications do your excipients carry?
A: All our excipients are certified to USP, EP, JP, and CE standards. We maintain FDA DMF (Drug Master File) and CEP (Certificate of Suitability) for European markets. Full documentation available upon request.
Q2: Can you match competitor pricing while maintaining quality?
A: Yes. Our vertical integration (from raw material to finished goods) and economies of scale allow us to offer 15β25% lower prices than EU/US suppliers without compromising quality. We provide cost comparisons upon request.
Q3: What's your minimum order quantity (MOQ)?
A: Our MOQ is 500kg for most products, with no minimum for samples. We understand the need for flexibility in development phases and offer tiered pricing for larger orders.
Q4: How do you ensure supply chain resilience?
A: We operate dual production hubs in China and India with parallel inventory. This ensures 98% on-time delivery even during geopolitical disruptions. All critical raw materials are sourced from multiple suppliers.
Q5: What's your lead time for custom orders?
A: Standard lead times are 4β8 weeks for production orders. For urgent needs, we offer expedited services (2β3 weeks) at a premium. Contact our team for rush quotes.
Q6: Do you offer regulatory support for filings?
A: Yes. We provide complete DMF documentation (FDA), CEP dossiers (EDQM), and certificate of analysis for all global pharmacopoeias. Our regulatory team assists with drug master file submissions.
Q7: Can you customize specifications beyond your standard ranges?
A: Absolutely. We specialize in custom viscosity, particle size, and purity profiles. Our R&D team works with clients to develop proprietary excipient blends for unique formulations. Consultation is free.
π Ready to Secure Your Excipient Supply Chain?
Join 500+ pharmaceutical manufacturers who trust Tangzhi Technology for reliable, high-quality excipients.
βοΈ Email: admin@tangzhicellulose.com
π Address: Room 2308, Dongsheng Plaza 2, No. 508 Zhongshan East Road, Changβan District, Shijiazhuang, Hebei, China
Β© 2026 Tangzhi Technology (Hebei) Co., Ltd. All rights reserved.
Trusted Excipient Partner for Pharma Manufacturers Worldwide